These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 191876)

  • 21. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
    Reches A; Eldor A; Salomon Y
    Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
    [No Abstract]   [Full Text] [Related]  

  • 22. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of human gastric mucosal adenylate cyclase activity by prostacyclin.
    Simon B; Kather H
    Digestion; 1979; 19(2):137-9. PubMed ID: 383560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
    Macfarlane DE; Mills DC; Srivastava PC
    Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
    [No Abstract]   [Full Text] [Related]  

  • 25. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin stimulation of canine platelet adenylate cyclase.
    Longenecker GL; Kopaciewicz LJ; Palmer SJ; Palmer GC
    Thromb Res; 1980 Jul 1-15; 19(1-2):119-24. PubMed ID: 7444848
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
    Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
    Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of platelet adenylate cyclase by adenosine.
    Jakobs KH; Saur W; Johnson RA
    Biochim Biophys Acta; 1979 Apr; 583(4):409-21. PubMed ID: 427219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
    Haslam RJ; Vanderwel M
    J Biol Chem; 1982 Jun; 257(12):6879-85. PubMed ID: 6177688
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostaglandin E1 action on adenylate cyclase activity and membrane lipids in platelets.
    Mruk J; Bakardjiev A; Burgermeister W
    Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):745-56. PubMed ID: 6957369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia.
    Colli S; Lombroso M; Maderna P; Tremoli E; Nicosia S
    Biochem Pharmacol; 1983 Jul; 32(13):1989-93. PubMed ID: 6347202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desensitization of prostaglandin-activated platelet adenylate cyclase.
    Cooper B; Schafer AI; Puchalsky D; Handin RI
    Prostaglandins; 1979 Apr; 17(4):561-71. PubMed ID: 461820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
    Nogimori K; Kajikawa N; Nishio S; Yajima M
    Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action.
    Seiler SM; Brassard CL; Federici ME; Buchanan JO; Zavoico GB; Fleming JS; Meanwell NA
    Thromb Res; 1994 Apr; 74(2):115-23. PubMed ID: 8029812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.
    Harris DN; Asaad MM; Phillips MB; Goldenberg HJ; Antonaccio MJ
    J Cyclic Nucleotide Res; 1979; 5(2):125-34. PubMed ID: 221552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of prostaglandin endoperoxides on platelet ultrastructure.
    Gerrard JM; White JG
    Am J Pathol; 1975 Aug; 80(2):189-202. PubMed ID: 169697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.